The leaders of 54 Commonwealth nations have built on their 2018 agreement to a multi-pronged approach for access to screenings and affordable vision treatments, by committing to increasing access to
A US startup has developed a virtual-reality-style headset to enhance everyday activities for the visually impaired. Vision Buddy’s developers say the headset allows low vision users to view their surroundings, see faces clearly and read medicine labels – the headset can zoom in or out or read print
A UK optometrist has developed a hand-held device to maintain the attention of patients with learning disabilities or dementia during eye examinations.
After a successful 2021 reunion, this year’s Silmo optical fair, from 23-26 September in Paris, offers an opportunity to plunge back into the frenzied pace of the optical industry, be inspired and get a glimpse of the future.
BI-X, the first potential treatment for diabetic macular ischaemia (DMI), a complication of diabetic retinopathy (DR), was well tolerated in a recent Phase 1/2a trial.
Vineet Chauhan, the Association of Dispensing Opticians New Zealand immediate past president, has re-joined the Essilor family as its New Zealand territory manager.
A study evaluating the extra workforce needed to cope with increasing burden of myopia management found it’s unlikely to overwhelm eyecare in the UK and Ireland. Researchers at the Centre for Eye
Mojo Vision’s augmented reality (AR) contact lens, featuring motion tracking and a pinhead-sized LED display that superimposes graphics on the wearer’s vision, has begun in-eye testing. The first to
In an international study, led by Professor Barbara Pierscionek from Anglia Ruskin University in the UK, a new drop treatment for cataracts has shown positive results, leading to hope that an alternative to surgery could soon be possible.
Is there ever such a thing as a genuinely new trend? Most of us have been around long enough to see fashions come around for a second, if not a third time. Take the current resurgence of ’90s wide-legged pants, halter-neck tops and John Lennon-esque glasses, which themselves took cues from their 197
Brooklyn-based start-up Betterlab is developing glasses to prevent myopia progression using artificial light.
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved faricimab (Roche, Vabysmo), the first bispecific antibody to treat neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO), for NHS patients in England.